𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1α,25-Dihydroxyvitamin D3inhibits the invasive potential of human breast cancer cellsin vitro

✍ Scribed by Christina Mørk Hansen; Thomas L. Frandsen; Nils Brünner; Lise Binderup

Publisher
Springer
Year
1994
Tongue
English
Weight
752 KB
Volume
12
Category
Article
ISSN
0262-0898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of RelB by 1,25-dihydroxyvita
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation
✍ Nora D. Mineva; Xiaobo Wang; Sanghwa Yang; Haoqiang Ying; Zhi-Xiong J. Xiao; Mic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

## Abstract Aberrant constitutive expression of the NF‐κB c‐Rel and RelA subunits in breast cancer cells was shown to promote their survival. Recently, we demonstrated that aggressive breast cancers constitutively express high levels of the RelB subunit, which promotes their more invasive phenotype

Effects of 1,25-dihydroxyvitamin D3 on c
Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells
✍ John A. Eisman; Robert L. Sutherland; M. Lynne McMenemy; Jean-Charles Fragonas; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

The replication of several human and animal cancer cell lines is regulated in vitro and in vivo by 1,25-dihydroxyvitamin D3 I 1 ,25-(OH),D3], the hormonally active form of vitamin Uj. We have examined the effects of concentrations of 1 ,25-(OH)2D3, which inhibit cellular replication, on the cell-cyc

Differentiating and antitumor activities
Differentiating and antitumor activities of 1α,25-dihydroxyvitamin D3 in vitro and 1α-hydroxyvitamin D3 in vivo on human osteosarcoma
✍ Dr. Hiroyuki Tsuchiya; Hajime Morishita; Katsuro Tomita; Yoshimichi Ueda; Motohi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 813 KB

## Abstract The differentiating and antitumor activities of 1α,25‐dihydroxyvitamin D~3~ (1α,25(OH)~2~D~3~) in vitro and 1α‐hydroxyvitamin D~3~ (1α(OH)D~3~) in vivo were studied with a human osteosarcoma cell line (OST strain). Antitumor activity was estimated with the use of 3‐(4,5‐dimethylthiazol)